Variables | BC‐TC (median (IQR)/%) | BC alone (median (IQR)/%) | p‐value |
---|---|---|---|
No. of patients | 423 | 317579 | |
BC clinical characteristics | |||
Age at BC diagnosis | 55 (46-65) | 60 (50-71) | < 0.001 |
Female | 423 (100) | 315808 (99.4) | 0.2 |
Tumor size in mm | 15 (10-25) | 17 (11-25) | 0.1 |
Tumor site | |||
Left | 223 (52.7) | 164071 (51.7) | 1 |
Right | 199 (47.0) | 152907 (48.1) | |
Unknown | 1 (0.2) | 601 (0.2) | |
TNM stage | |||
0 | 38 (9.0) | 29125 (9.2) | |
I | 154 (36.4) | 112063 (35.3) | 0.3 |
II | 176 (41.6) | 122649 (38.6) | |
III | 43 (10.2) | 33816 (10.6) | |
IV | 9 (2.1) | 16746 (5.3) | |
M | 0 (0.0) | 1562 (0.5) | |
Unknown | 3 (0.7) | 1618 (0.5) | |
ER-positivity | 201 (87.41) | 151727 (82.61) | 0.1 |
PR-positivity | 154 (67.81) | 120837 (67.01) | 0.8 |
HER2-positivity | 35 (17.51) | 23810 (14.81) | 0.5 |
BC surgery2 | 406 (96.0) | 286592 (90.2) | <0.001 |
Breast-conserving | 226 (53.3) | 163501 (51.5) | |
Ablative | 168 (39.7) | 13995 (35.9) | |
Surgery NNO | 12 (2.8) | 8867 (2.8) | |
BC radiation therapy | 270 (63.8) | 186779 (58.8) | 0.04 |
BC chemotherapy | 158 (37.4) | 97895 (30.8) | <0.001 |
BC hormone therapy | 191 (45.2) | 140908 (44.4) | 0.7 |
TC clinical characteristics | |||
Age at TC diagnosis | 62 (52-72) | ||
Tumor size in mm | 15 (8-25) | ||
Papillary thyroid cancer | 331 (78.3) | ||
Follicular thyroid cancer | 81 (19.1) | ||
Unknown histology | 11 (2.6) | ||
Lymph node metastasis | 98 (23.2) | ||
Distant metastasis | 11 (2.6) |